SYK
Stryker Corporation · Healthcare · Medical - Devices
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -3.5% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 172 | +2 | 222.54M | $70.41B | +7 | −4 |
| Q1 2026 | 172 | -2 | 215.42M | $70.87B | +1 | −4 |
| Q4 2025 | 173 | -1 | 229.53M | $80.67B | +1 | −1 |
| Q3 2025 | 25 | +3 | 142.80M | $52.79B | +4 | −2 |
| Q2 2025 | 20 | 0 | 117.11M | $46.33B | +1 | −1 |
| Q1 2025 | 17 | -2 | 51.08M | $19.01B | — | −2 |
| Q4 2024 | 19 | 0 | 52.07M | $18.75B | +1 | −1 |
| Q3 2024 | 18 | +2 | 39.19M | $14.15B | +2 | — |
| Q2 2024 | 16 | — | 41.27M | $14.03B | — | — |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 14.78M | — | $5.33B | 0.2% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 11.11M | +0.5% | $4.00B | 0.5% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 8.38M | -17.0% | $3.02B | 0.6% | ▼ Trim | 3 | SEC ↗ ×7 |
| 4 | Geode Capital Management ✦ (被动) | 7.07M | +2.4% | $2.54B | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (被动) | 4.75M | -0.6% | $1.71B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 6 | Fisher Asset Management ✦ | 4.08M | -3.8% | $1.47B | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 607.20K | -8.9% | $218.62M | 0.3% | ▼ Trim | 3 | SEC ↗ ×2 |
| 8 | PRIMECAP Management ✦ | 436.10K | -2.5% | $157.02M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 214.24K | 新增 | $77.14M | 0.2% | New | 1 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 144.39K | -18.6% | $51.99M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 135.67K | -29.5% | $48.85M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 101.04K | -19.0% | $36.38M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 13 | Arrowstreet Capital ✦ | 96.09K | -67.5% | $34.60M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Millennium Management ✦ | 73.64K | +136.0% | $26.52M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 39.87K | -32.7% | $14.35M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 16 | GAMCO Investors ✦ | 21.57K | +17.1% | $7.77M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 18.14K | -52.1% | $6.53M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 18 | Gotham Asset Management ✦ | 4.25K | +139.8% | $1.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Marshall Wace ✦ | 2.90K | -80.2% | $1.04M | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $77.14M | 0.2% |
已清仓
| Renaissance Technologies | $16.40M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 2,274 持有人, 283.44M 股份, $87.41B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Director · 18 股 @ 225.19 · $4,054
Director · 3 股 @ 185.65 · $557
Director · 36 股 @ 193.21 · $6,956
Director · 11 股 @ 221.03 · $2,431
Director · 63 股 @ 202.21 · $12,739
公开市场卖出 (S)
Officer · 441 股 · $144,915
Director · 11.26K 股 · $3.81M
Director · 40 股 · $13,272
Director · 440 股 · $146,598
Director · 200 股 · $66,786
Director · 80 股 · $26,804
Director · 320 股 · $107,774
Director · 2.31K 股 · $780,062
Director · 10.81K 股 · $3.67M
Director · 16.61K 股 · $5.66M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论